首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   20676篇
  免费   997篇
  国内免费   519篇
耳鼻咽喉   12篇
儿科学   249篇
妇产科学   80篇
基础医学   1753篇
口腔科学   81篇
临床医学   2972篇
内科学   6835篇
皮肤病学   75篇
神经病学   334篇
特种医学   1052篇
外科学   1416篇
综合类   3154篇
预防医学   859篇
眼科学   31篇
药学   2339篇
  7篇
中国医学   743篇
肿瘤学   200篇
  2023年   148篇
  2022年   368篇
  2021年   477篇
  2020年   488篇
  2019年   342篇
  2018年   399篇
  2017年   396篇
  2016年   469篇
  2015年   596篇
  2014年   1299篇
  2013年   1274篇
  2012年   1094篇
  2011年   1246篇
  2010年   1145篇
  2009年   1214篇
  2008年   1228篇
  2007年   1241篇
  2006年   1222篇
  2005年   1006篇
  2004年   789篇
  2003年   710篇
  2002年   573篇
  2001年   539篇
  2000年   463篇
  1999年   392篇
  1998年   322篇
  1997年   278篇
  1996年   213篇
  1995年   234篇
  1994年   198篇
  1993年   138篇
  1992年   128篇
  1991年   128篇
  1990年   126篇
  1989年   119篇
  1988年   114篇
  1987年   117篇
  1986年   72篇
  1985年   103篇
  1984年   111篇
  1983年   67篇
  1982年   80篇
  1981年   70篇
  1980年   72篇
  1979年   68篇
  1978年   72篇
  1977年   45篇
  1976年   55篇
  1975年   31篇
  1973年   32篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
冠心病患者血栓前状态分子标志物的变化   总被引:5,自引:1,他引:4  
观察冠心病患者凝血、纤溶指标的变化 ,以探讨凝血系统的变化与冠心病发病的关系。采用酶联免疫吸附双抗体夹心法检测 10 0例冠心病患者血浆D 二聚体、血小板α颗粒膜蛋白 14 0及血管性血友病因子含量 ,并与4 4例健康人比较。结果发现 ,冠心病患者血浆D 二聚体、血小板α颗粒膜蛋白 14 0和血管性血友病因子明显升高 ,与对照组比较差异显著 (P <0 .0 1) ,且急性心肌梗死患者各指标变化明显高于陈旧性心肌梗死、不稳定型心绞痛和稳定型心绞痛患者 (P <0 .0 1) ,其中不稳定型心绞痛患者血浆血小板α颗粒膜蛋白 14 0明显高于稳定型心绞痛患者 (P <0 .0 5 )。冠心病患者血小板α颗粒膜蛋白 14 0、血管性血友病因子及D 二聚体水平之间呈明显的正相关性(P <0 .0 5 )。结果提示 ,冠心病患者存在明显的高凝状态 ,表现为继发性纤溶亢进 ,血小板活性增加及血管内皮细胞损伤 ,且与冠心病患者的病情变化有一定关系。  相似文献   
52.
Mycotoxin toxicosis has been implicated in the etiopathogenesis of Keshan disease (KD), an endemic cardiomyopathy prevailing in some regions of China. Butenolide (4-acetamido-4-hydroxy-2-butenoic acid gamma-lactone, CAS No. 16275-44-8), a mycotoxin produced by several Fusarium species such as Fusarium tricinctum and Fusarium graminearum, is frequently detected from the cereals in the endemic areas of KD. The present study is undertaken to investigate whether this mycotoxin can induce myocardial damage. Exposure of primary culture of cardiac myocytes to butenolide resulted in significant cytotoxicity, manifested by changes in cell morphology and decreases in cell viability. Consistent with the in vitro findings, distinct myocardial toxicity in vivo was observed after administration of rats by gavage with butenolide (10 and 20 mg/kg/day) for 2 months, and the myocardial injuries were characterized by focal necrosis of myocardium and fragmentation of myofiber. Butenolide also induced significant oxidative damage to the myocardium in vitro evidenced by a concentration-dependent lipid peroxidation in the myocardial homogenates, whereas antioxidants superoxide dismutase (SOD), N-acetylcysteine (NAC) and glutathione (GSH) provided significant protections against this oxidative effect. Taken together, these results clearly reveal that butenolide possesses the potential to induce myocardial toxicity. The present findings may reinforce the hypothesis that toxicosis by mycotoxins is one of the etiological factors for KD.  相似文献   
53.
To evaluate the usefulness of myocardial scintigraphy as a monitoring tool for chronic doxorubicin (DXR) cardiotoxicity, a rat model was used to investigate the relationship between the myocardial uptake of thallium 201 (Tl) or rechnetium 99m pyrophosphate (99mTc-PPi) and histological changes of the heart. Although there was no significant difference in myocardial Tl uptake between control and DXR-treated rats at an early phase after Tl injection, late-phase Tl uptake was significantly higher in the DXR-treated rats than in the control rats, indicating a slow wash-out of Tl from the myocardium. The wash-out rate calculated from scintigraphic examination of DXR-treated rats was significantly decreased with increasing degree of cardiomyopathy. Since the Tl wash-out rate was sharply decreased even in animals with minimal histological changes, it may be a possible monitoring tool for the early detection of chronic DXR cardiotoxicity. On the other hand, myocardial99mTc-PPi images could be obtained only in rats with severe myocardial changes and hence would not useful for early detection.  相似文献   
54.
BACKGROUND: Coupled pacing (CP), which consists of delivering a premature electrical stimulation to the heart after the effective refractory period of ventricular activation, is a novel method for controlling ventricular rate during atrial fibrillation (AF). It also has been established that CP improves pump function by enhancing external cardiac work and myocardial efficiency. OBJECTIVE: The purpose of the present study was to determine if two time delays for CP (short and long) would result in similar improvements in ventricular function. METHODS: In a canine model, we applied CP at two time delays (CP-S and CP-L) during two stages: sinus rhythm (SR) and acute AF. The cardiac responses to CP during SR served as the nontachycardic and nondepressed control. During both rhythms, we shortened the coupling interval until we obtained maximal contractility, designated CP-S. Next, we increased the delay until we started to see a measurable secondary contraction (left ventricular pressure development of approximately 20 mmHg). These longer delays were designated CP-L. RESULTS: Our results showed that the ventricular rate of intrinsic activation (VRIA) remained decreased despite prolongation of the time delay of CP during both AF and SR. Also, both delays of CP increased left ventricular systolic pressure (LVSP) and dLVP/dt, which are indices of myocardial contractility. In contrast, CP increased external cardiac work only during AF. Prolonging this time delay did not markedly decrease the improvement in external cardiac work. Myocardial O(2) consumption (MVO(2)) did not significantly change as the result of CP during either SR or AF. Finally, myocardial efficiency improved during AF as the result of CP at both time delays. CONCLUSIONS: In conclusion, shorter time delays for CP increased contractile strength during both SR and AF. However, extending the time delay of CP had minimal effects on diminishing the improved ventricular pump function and energetics that resulted from CP during AF. Thus, the maximal enhancement of myocardial contractility via CP-S was not needed to maintain the improved ventricular function during acute AF when CP is applied.  相似文献   
55.
促红细胞生成素心肌保护作用的研究进展   总被引:4,自引:0,他引:4  
促红细胞生成素(erythropoietin,EPO)是一种造血细胞生长因子,主要用于治疗多种原因所致的贫血。近年来其非造血生物作用逐渐引起关注,EPO具有组织保护作用,这一作用涉及多种不同组织和细胞,心肌保护一直是心血管病研究领域重要、关键的课题。EPO对心肌保护的作用近两年已渐有报道,这无疑为临床心肌保护的研究提供了新的思路和方向。现就EPO心肌保护作用的相关研究成果、发现以及有待解决的问题作一综述。  相似文献   
56.
老年人急性心肌梗塞的临床特点   总被引:2,自引:0,他引:2  
目的:研究60岁以上老年人急性心肌梗塞的临床特点。方法:对86例老年人急性心肌梗塞资料进行临床分析,并与同期255例小于60岁的急性心肌梗塞病人进行对比。结果:老年急性心肌梗塞患者女性的比例较60岁以下者明显增多(P<0.01),老年无痛性心肌梗塞比例(30.5%)明显增多(P<0.05),并发症心力衰竭(P<0.01)、心律失常(P< 0.05),死亡率(P<0.01)也明显增多。结论:老年人无痛性急性心肌梗塞多见,并发症发生率、死亡率高,应予重视。  相似文献   
57.
目的探讨64层螺旋CT冠状动脉成像对心肌桥(MB)的诊断及其临床价值。资料与方法1422例患者均行64层CT扫描,所有数据传至工作站进行重组和后处理,观察有无MB,测量MB的长度、厚度、壁冠状动脉狭窄程度等。所有MB病例均行冠状动脉造影(CAG)检查并与CT结果对比。结果共发现104例119段MB,平均长度及厚度分别为(5.0±2.7)mm、(2.0±1.6)mm,壁冠状动脉狭窄程度为(31±17)%。104例MB患者CAG发现42例44段MB,其长度、厚度与CT结果存在明显差异。结论64层CT对MB和壁冠状动脉清晰显示,有特殊的临床价值。  相似文献   
58.
健康教育在心肌梗死中应对无效的原因及对策   总被引:3,自引:2,他引:1  
目的:探讨健康教育在心肌梗死中应对无效的原因与对策。方法:收治心肌梗死16例,2例突发心衰死亡,3例超过此病的平均住院天数。结果:表明部分心肌梗死患的健康教育应对无效。结论:通过对心肌梗死患健康教育的效果观察,发现部分患应对无效。患方面的原因有(1)对疾病认识不足;(2)化层次差别大;(3)家属未积极配合;(4)对护士的信任度偏低。护士方面的原因有(1)对健康教育的落实力度不够;(2)不能充分利用有效的时间;(3)缺乏健康教育能力。提出的对策有(1)认真评估患,有针对性地进行教育;(2)强化角色意识,明确护士在健康教育中的地位和作用;(3)优化教育内容;(4)加大培训力度;(5)鼓励患家属积极参与;(6)建立良好的护患关系。  相似文献   
59.
目的:通过骨髓细胞移植对心肌梗死大鼠模型血管内皮生长因子及其受体表达的影响,探讨骨髓细胞移植改善缺血心脏功能的可能机制。方法:利用左前降支冠状动脉结扎术制备大鼠心肌梗死模型,然后行异体骨髓细胞移植;分别于术后1d,3d,7d,14d和28d取材;利用免疫荧光和RT—PCR技术分析细胞移植对血管内皮生长因子(VEGF)及其受体(Flk一1)表达的影响和移植细胞的分化情况;通过免疫组化计算血管数量;应用血流动力学检测大鼠心脏功能在术后各时间点的变化。结果:VEGF和Flk-1在移植组动物的心肌梗死区残存细胞、梗死周边区细胞以及部分移植细胞内表达。移植组VEGF和Flk-1的mRNA表达明显高于对照组。分别于术后3d和14d达到高峰,以后逐渐减弱。术后7d,14d和28d移植组血管数量较同期对照组明显增加,移植组心脏功能较对照组明显改善。术后14d可在部分移植细胞中检测到心肌细胞或血管内皮细胞特异性蛋白的表达。结论:骨髓细胞移植通过上调移植细胞及受者内源性VEGF和Flk—1的表达,促进血管新生,进而改善缺血心脏功能。  相似文献   
60.
BACKGROUND: Our objective was to determine the cost-effectiveness of a comprehensive, risk-based triage system, composed of multiple critical pathways, with the use of early myocardial perfusion imaging (MPI) in low-risk patients. We found previously that a chest pain evaluation system that uses MPI in low-risk patients was safe and effective, but the cost-effectiveness of this approach was not studied. METHODS AND RESULTS: We compared two groups. The Acute Cardiac Team (ACT) group (n = 874) was assigned prospectively to 1 of 4 risk levels by emergency department (ED) physicians. Level 1, 2, and 3 patients were admitted; level 4 patients were evaluated in the ED. Level 3 and 4 patients underwent ED MPI. The control group (n = 713) represented consecutive patients evaluated in the prior year according to standard care and assigned retrospectively to an ACT level based on the presenting electrocardiographic and clinical data. Record and hospital administrative data were assessed for clinical variables, outcomes, lengths of stay, and all expenses incurred within 30 days of the index visit. The baseline characteristics of the two groups were similar, including age, sex, myocardial infarction prevalence, and 30-day revascularization rates within each level or between the two groups. Mean costs per encounter were reduced for the ACT patients for each level, which was significant when all patients were compared ($5,030 +/- $7,081 vs $6,044 +/- $10,432, P =.02). Use of MPI in the low-risk patients was associated with reduced costs (level 3, $4,958 +/- $4,948 vs $5,051 +/- $7,036; level 4, $1,529 +/- $2,664 vs $1,794 +/- $6,854) and was associated with a significantly lower angiography rate and shorter length of stay. CONCLUSIONS: Implementation of a comprehensive strategy for chest pain evaluation and triage reduced overall costs for patients with chest pain on presentation. Acute MPI in the ED setting did not increase net cost.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号